Literature DB >> 1575261

Low cerebellar metabolism in medicated patients with chronic schizophrenia.

N D Volkow1, A Levy, J D Brodie, A P Wolf, R Cancro, P Van Gelder, F Henn.   

Abstract

Because of the frequent association of cerebellar structural defects with schizophrenia, the authors reanalyzed the metabolic brain images of patients with chronic schizophrenia to assess if they had abnormalities in cerebellar metabolism. They used carbon-11-2-deoxyglucose and positron emission tomography to study 18 medicated patients with chronic schizophrenia and 12 normal comparison subjects. Patients with schizophrenia showed significantly lower absolute and relative metabolism in the cerebellum than normal subjects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575261     DOI: 10.1176/ajp.149.5.686

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  9 in total

1.  Cerebellar projections to the prefrontal cortex of the primate.

Authors:  F A Middleton; P L Strick
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

2.  Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate.

Authors:  Michael Michaelides; Javier Pascau; Juan-Domingo Gispert; Foteini Delis; David K Grandy; Gene-Jack Wang; Manuel Desco; Marcelo Rubinstein; Nora D Volkow; Panayotis K Thanos
Journal:  Eur J Neurosci       Date:  2010-07-16       Impact factor: 3.386

Review 3.  Emotion and Theory of Mind in Schizophrenia-Investigating the Role of the Cerebellum.

Authors:  Omar Mothersill; Charlotte Knee-Zaska; Gary Donohoe
Journal:  Cerebellum       Date:  2016-06       Impact factor: 3.847

Review 4.  The role of the cerebellum in schizophrenia.

Authors:  Nancy C Andreasen; Ronald Pierson
Journal:  Biol Psychiatry       Date:  2008-04-08       Impact factor: 13.382

5.  Consensus Paper: Cerebellum and Social Cognition.

Authors:  Frank Van Overwalle; Mario Manto; Zaira Cattaneo; Silvia Clausi; Chiara Ferrari; John D E Gabrieli; Xavier Guell; Elien Heleven; Michela Lupo; Qianying Ma; Marco Michelutti; Giusy Olivito; Min Pu; Laura C Rice; Jeremy D Schmahmann; Libera Siciliano; Arseny A Sokolov; Catherine J Stoodley; Kim van Dun; Larry Vandervert; Maria Leggio
Journal:  Cerebellum       Date:  2020-12       Impact factor: 3.847

6.  Cerebellar-dependent eyeblink conditioning deficits in schizophrenia spectrum disorders.

Authors:  Jennifer K Forsyth; Amanda R Bolbecker; Crystal S Mehta; Mallory J Klaunig; Joseph E Steinmetz; Brian F O'Donnell; William P Hetrick
Journal:  Schizophr Bull       Date:  2010-12-09       Impact factor: 9.306

7.  Impaired cerebellar-dependent eyeblink conditioning in first-degree relatives of individuals with schizophrenia.

Authors:  Amanda R Bolbecker; Jerillyn S Kent; Isaac T Petersen; Mallory J Klaunig; Jennifer K Forsyth; Josselyn M Howell; Daniel R Westfall; Brian F O'Donnell; William P Hetrick
Journal:  Schizophr Bull       Date:  2013-08-20       Impact factor: 9.306

8.  Increased timing variability in schizophrenia and bipolar disorder.

Authors:  Amanda R Bolbecker; Daniel R Westfall; Josselyn M Howell; Ryan J Lackner; Christine A Carroll; Brian F O'Donnell; William P Hetrick
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

Review 9.  Eyeblink Conditioning in Schizophrenia: A Critical Review.

Authors:  Jerillyn S Kent; Amanda R Bolbecker; Brian F O'Donnell; William P Hetrick
Journal:  Front Psychiatry       Date:  2015-12-18       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.